[Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples